載入中
Lifeward Ltd. is a healthcare technology company specializing in the creation, development, and commercialization of wearable robotic exoskeletons. These sophisticated devices are engineered to restore lower limb mobility for individuals living with spinal cord injuries (SCI), granting them the ability to stand, walk, pivot, and navigate staircases by providing assistive hip and knee motion. Key offerings from the company include the ReWalk Exo-Suit and the ReWalk Personal 6.0. Founded by Amit Goffer on June 20, 2001, the enterprise maintains its corporate headquarters in Marlborough, Massachusetts.
前收盤價
US$6.49
+US$0.06 · +0.93%
盤中時間採用ET。市場資料可能有所延遲。
Lifeward Ltd. is a healthcare technology company specializing in the creation, development, and commercialization of wearable robotic exoskeletons. These sophisticated devices are engineered to restore lower limb mobility for individuals living with spinal cord injuries (SCI), granting them the ability to stand, walk, pivot, and navigate staircases by providing assistive hip and knee motion. Key offerings from the company include the ReWalk Exo-Suit and the ReWalk Personal 6.0. Founded by Amit Goffer on June 20, 2001, the enterprise maintains its corporate headquarters in Marlborough, Massachusetts.
日內區間
目前US$6.49
52週區間
目前US$6.49
盤中時間採用ET。市場資料可能有所延遲。
Lifeward Ltd. is a healthcare technology company specializing in the creation, development, and commercialization of wearable robotic exoskeletons. These sophisticated devices are engineered to restore lower limb mobility for individuals living with spinal cord injuries (SCI), granting them the ability to stand, walk, pivot, and navigate staircases by providing assistive hip and knee motion. Key offerings from the company include the ReWalk Exo-Suit and the ReWalk Personal 6.0. Founded by Amit Goffer on June 20, 2001, the enterprise maintains its corporate headquarters in Marlborough, Massachusetts.
日內區間
目前US$6.49
52週區間
目前US$6.49
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 2203.4萬 USD | 2566.3萬 USD | 1385.4萬 USD | 551.1萬 USD | 596.6萬 USD |
| 銷貨成本 | 1360.6萬 USD | 1744.7萬 USD | 940.1萬 USD | 360.6萬 USD | 306.3萬 USD |
| 毛利 | 842.8萬 USD | 821.6萬 USD | 445.3萬 USD | 190.5萬 USD | 290.3萬 USD |
| 研究與開發 | 324.9萬 USD | 462.5萬 USD | 414.8萬 USD | 403.1萬 USD | 293.9萬 USD |
| 銷售、一般及管理費用 | 2207萬 USD | 2314.4萬 USD | 2391.7萬 USD | 1697.6萬 USD | 1261.9萬 USD |
| 營業費用 | 2531.9萬 USD | 2776.9萬 USD | 2806.5萬 USD | 2100.7萬 USD | 1555.8萬 USD |
| 利息收入 | — | 64.3萬 USD | 135.4萬 USD | — | — |
| 利息支出 | 29.5萬 USD | 12.8萬 USD | 2萬 USD | 2.2萬 USD | 2.5萬 USD |
| 折舊和攤銷 | 33.3萬 USD | 384.1萬 USD | 184.7萬 USD | 20.2萬 USD | 26.6萬 USD |
| 營業利益 | −1689.1萬 USD | −1955.3萬 USD | −2361.2萬 USD | −1910.2萬 USD | −1265.5萬 USD |
| 淨利 | −1991.4萬 USD | −2894.2萬 USD | −2213.3萬 USD | −1956.9萬 USD | −1273.6萬 USD |
公司資料更新於 2026年10月11日。
近期已公布業績
近期已公布業績
第三方分析師預期可能變動，並非 GoAI 建議。
平均目標
US$10.00
上漲空間 54.08%| 行動 | 生效日期 | 詳情 | 記錄日期 | 付款日期 |
|---|---|---|---|---|
股票分割 | 2026年2月24日 | 1:12 | — | — |
股票分割 | 2024年3月15日 | 1:7 | — | — |
股票分割 | 2019年4月1日 | 1:25 | — | — |
已生效 2026年2月24日
1:12
已生效 2024年3月15日
1:7
已生效 2019年4月1日
1:25
報告持有此股票曝險的交易所交易基金。
AI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
